ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,761Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 680

$852K Total Retail Price of All Prescriptions

Rank: 120 out of 680

933 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 933 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 933 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 14,473 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 614 526 1 2
AMLODIPINE BESYLATE 544 479 2 1
SIMVASTATIN 475 416 3 3
LISINOPRIL 462 385 4 5
METFORMIN HCL 431 373 5 8
OMEPRAZOLE 372 336 6 7
METOPROLOL TARTRATE 353 287 7 12
HYDROCODONE-ACETAMINOPHEN 331 207 S3 8 4
LOVASTATIN 320 302 9 44
LOSARTAN POTASSIUM 302 218 10 21
HYDROCHLOROTHIAZIDE 300 277 11 9
ATENOLOL 296 214 12 19
PANTOPRAZOLE SODIUM 290 271 13 30
METOPROLOL SUCCINATE 286 260 14 13
FUROSEMIDE 276 220 15 6
ZOLPIDEM TARTRATE 268 188 16 17
MELOXICAM 255 222 17 24
ATORVASTATIN CALCIUM 255 236 17 11
ALPRAZOLAM 232 174 19 72
SYNTHROID 215 207 20 38
SERTRALINE HCL 212 171 21 28
CITALOPRAM HBR 207 187 22 22
GABAPENTIN 201 156 23 15
PRAVASTATIN SODIUM 200 188 24 10
POTASSIUM CHLORIDE 200 157 24 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 185 161 26 37
TRAMADOL HCL 176 114 27 18
GLYBURIDE 164 145 R 28 85
TAMSULOSIN HCL 163 146 29 34
CRESTOR 156 116 30 25
JANUVIA 153 129 31 60
PROAIR HFA 143 124 32 67
LEVOCETIRIZINE DIHYDROCHLORIDE 138 109 33 216
AZITHROMYCIN 137 106 34 42
SPIRIVA 135 113 35 70
NEXIUM 134 86 36 16
ATENOLOL-CHLORTHALIDONE 127 115 37 205
AMLODIPINE BESYLATE-BENAZEPRIL 127 106 37 43
CLOPIDOGREL 125 107 39 26
AMITRIPTYLINE HCL 121 45 R 40 47
CLONIDINE HCL 111 85 41 36
DIOVAN 111 93 41 31
PLAVIX 109 94 43 39
ALENDRONATE SODIUM 106 104 44 32
NIFEDIPINE ER 104 104 45 75
BENAZEPRIL HCL 103 98 46 40
RANITIDINE HCL 99 68 47 56
ALLOPURINOL 99 84 47 33
CARVEDILOL 96 92 49 23
DONEPEZIL HCL 95 95 50 27
HYDRALAZINE HCL 95 84 50 71
TRAMADOL HCL-ACETAMINOPHEN 94 68 52 153
GLYBURIDE-METFORMIN HCL 92 64 R 53 107
LOSARTAN-HYDROCHLOROTHIAZIDE 91 79 54 51
ACETAMINOPHEN-CODEINE 90 60 S3 55 175
BUMETANIDE 84 62 56 102
LANTUS SOLOSTAR 83 70 57 84
CYMBALTA 82 34 58 46
LABETALOL HCL 79 68 59 158
DIAZEPAM 79 48 59 188
LANTUS 75 48 61 49
FLUOXETINE HCL 75 65 61 74
ROPINIROLE HCL 74 61 63 99
DIOVAN HCT 73 63 64 55
LYRICA 72 53 65 77
TRIAMTERENE-HCTZ 69 61 66 52
LORAZEPAM 69 55 66 125
GLIPIZIDE 69 68 66 63
VIAGRA 67 61 69 214
ADVAIR DISKUS 67 51 69 53
SINGULAIR 66 50 71 91
ENALAPRIL MALEATE 65 33 72 65
INSULIN SYRINGE 65 40 72 86
MIRTAZAPINE 65 43 72 78
NABUMETONE 64 58 75 174
DOXAZOSIN MESYLATE 64 51 75 73
GEMFIBROZIL 63 57 77 106
CELEBREX 62 62 78 90
NIFEDICAL XL 60 57 79 220
FLUTICASONE PROPIONATE 59 50 80 41
LANSOPRAZOLE 59 40 80 184
SPIRONOLACTONE 58 54 82 82
PAROXETINE HCL 57 38 83 76
ISOSORBIDE MONONITRATE ER 57 55 83 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 52 85 94
QUINAPRIL HCL 53 52 86 104
FINASTERIDE 53 46 86 109
LEVOFLOXACIN 53 44 86 97
LIPITOR 52 51 89 68
DETROL LA 52 51 89 169
VENLAFAXINE HCL ER 51 14 91 101
METHYLPREDNISOLONE 50 39 92 93
GLIPIZIDE ER 50 46 92 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.